Munich, Germany

Katharina Kolberg

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katharina Kolberg. Retrieved from https://idiyas.com/inventor/katharina-kolberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katharina Kolberg: Innovator in Monoclonal Antibody Development

Introduction

Katharina Kolberg is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has led to advancements in detection technologies that are crucial for various applications in research and diagnostics.

Latest Patents

Katharina Kolberg holds a patent for a monoclonal antibody designed for the detection of SNAP/CLIP tags. This antibody specifically binds to the SNAP motif and the CLIP tag, incorporating CDRs with the amino acid sequences SEQ ID Nos. 3, 4, 5, and 8, 9, 10. This invention represents a significant step forward in the ability to detect and utilize these tags in various scientific applications.

Career Highlights

Kolberg is affiliated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., a leading organization in applied research. Her work at this institution has allowed her to collaborate with other experts in the field and contribute to groundbreaking research initiatives.

Collaborations

Some of her notable coworkers include Stefan Barth and Christiane Püttmann. Their collaborative efforts have further enhanced the impact of her research and innovations in the field of biotechnology.

Conclusion

Katharina Kolberg's contributions to the development of monoclonal antibodies exemplify her dedication to advancing scientific research. Her innovative patent and collaborations with esteemed colleagues highlight her role as a key figure in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…